Andersons pediatric cardiology 1580

Fatalinfantilecardiopathycausedby
phosphorylasebkinasedeficiency.JPediatr.
1988;113:82–85.
27.AmitR,BashanN,AbarbanelJM,etal.Fatal
familialinfantileglycogenstoragedisease:
multisystemphosphofructokinasedeficiency.
MuscleNerve.1992;15:455–458.
28.FinstererJ,StollbergerC,KopsaW.Neurolgic
andcardiacprogressionofglycogenosistypeVII
overaneight-yearperiod.SouthMedJ.
2002;95(12):1436–1440.
29.TaylorD,BlaserSI,BurrowsPE,etal.
Arteriopathyandcoarctationoftheabdominal
aortainchildrenwithmucopolysaccharidosis:
imagingfindings.AJRAmJRoentgenol.
1991;157:819–823.
30.BolourchiM,RenellaP,WangRY.Aorticroot
dilatationinmucopolysaccharidosisI-VII.IntJ
MolSci.2016;17(12):pii:E2004.
31.ScottHS,BungeS,GalA,etal.Molecular
geneticsofmucopolysaccharidosistypeI:
diagnostic,clinical,andbiologicalimplications.
HumMutat.1995;6(4):288–302.
32.TerlatoNJ,CoxGF.Canmucopolysaccharidosis
typeIdiseaseseveritybepredictedbasedona
patient'sgenotype?Acomprehensivereviewof
theliterature.GenetMed.2003;5(4):286–294.


33.ClarkeLA.MucopolysaccharidosistypeI.Pagon
RA,AdamMP,ArdingerHH,etal.

GeneReviews.UniversityofWashington,:
Seattle(WA);2002[Seattle;1993-2017;
[updated2016Feb11].
34.DonaldsonMDC,PennockCA,BerryPJ,etal.
Hurlersyndromewithcardiomyopathyin
infancy.JPediatr.1989;114:429–430.
35.StephanMJ,StevensELJr,WenstrupRJ,etal.
MucopolysaccharidosisIpresentingwith
endocardialfibroelastosisininfancy.AmJDis
Child.1989;143(7):782–784.
36.KrovetzLJ,LorinczAE,SchieblerGI.
Cardiovascularmanifestationsofthehurler
syndrome:hemodynamicand
angiocardiographicobservationsin15patients.
Circulation.1965;31:132–141.
37.HinekA,WilsonSE.Impairedelastogenesisin
hurlerdisease:dermatansulfateaccumulation
linkedtodeficiencyinelastin-bindingprotein
andelasticfiberassembly.AmJPathol.
2000;156(3):925–938.
38.KrivitW.Allogeneicstemcelltransplantationfor
thetreatmentoflysosomalandperoxisomal
metabolicdiseases.SpringerSemin
Immunopathol.2004;26(1–2):119–132.
39.BraunlinEA,BerryJM,WhitleyCB.Cardiac


findingsafterenzymereplacementtherapyfor
mucopolysaccharidosistypeI.AmJCardiol.
2006;98(3):416–418.

40.FischerTA,LehrHA,NixdorffU,MeyerJ.
Combinedaorticandmitralstenosisin
mucopolysaccharidosistypeI-S(ullrich-scheie
syndrome).Heart.1999;81(1):97–99.
41.MinakataK,KonishiY,MatsumotoM,MiwaS.
SurgicaltreatmentforScheie'ssyndrome
(mucopolysaccharidosistypeI-S):reportoftwo
cases.JpnCircJ.1998;62(9):700–703.
42.GrossDM,WilliamsJC,CaprioliC,Domingues
B,HowellRR.Echocardiographicabnormalities
inthemucopolysaccharidestoragediseases.Am
JCardiol.1988;61:170–176.
43.Sukegawa-HayasakaK,KatoZ,NakamuraH,et
al.Effectofhunterdisease
(mucopolysaccharidosistypeII)mutationson
molecularphenotypesofiduronate-2-sulfatase:
enzymaticactivity,proteinprocessingand
structuralanalysis.JInheritMetabDis.
2006;29(6):755–761.
44.TuschlK,GalA,PaschkeE,KircherS,Bodamer
OA.MucopolysaccharidosistypeIIinfemales:
casereportandreviewofliterature.Pediatr
Neurol.2005;32(4):270–272.
45.MuenzerJ,Gucsavas-CalikogluM,McCandless